A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

被引：0
|
作者：
Takeo Fujii
Hiroko Masuda
Yee Chung Cheng
Fei Yang
Aysegul A. Sahin
Yasuto Naoi
Yuki Matsunaga
Akshara Raghavendra
Arup Kumar Sinha
Jose Rodrigo Espinosa Fernandez
Anjali James
Keisuke Yamagishi
Tomoko Matsushima
Robert Schuetz
Debu Tripathy
Sachiyo Tada
Rubie S. Jackson
Shinzaburo Noguchi
Seigo Nakamura
Jared D. Acoba
Naoto T. Ueno
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Breast Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, Unit 1354
[3] University of Hawai’i,John A. Burns School of Medicine
[4] University of Hawai’i Cancer Center,Department of Breast Surgical Oncology
[5] Showa University,Division of Hematology and Oncology
[6] Medical College of Wisconsin,Department of Translational Molecular Pathology
[7] The University of Texas MD Anderson Cancer Center,Department of Pathology
[8] The University of Texas MD Anderson Cancer Center,Department of Breast and Endocrine Surgery
[9] Osaka University Graduate School of Medicine,Anne Arundel Medical Center
[10] Sysmex Corporation,undefined
[11] Rebecca Fortney Breast Center,undefined
[12] Hyogo Prefectural Nishinomiya Hospital,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 189卷
关键词：
Breast cancer; 21-gene signature assay; 95-gene signature assay; Estrogen receptor-positive; Recurrence Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：455 / 461
页数：6
相关论文
共 50 条
  • [41] Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer
    Shin, Gi Won
    Zhang, Yang
    Kim, Min Jung
    Su, Min-Ying
    Kim, Eun-Kyung
    Moon, Hee Jung
    Yoon, Jung Hyun
    Park, Vivian Youngjean
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 48 (06) : 1678 - 1689
  • [42] Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer
    Loughman, Tony
    Barron, Stephen
    Wang, Chan-Ju Angel
    Dynoodt, Peter
    Fender, Bozena
    Lopez-Ruiz, Cesar
    Stapleton, Sharon
    Fabre, Aurelie
    Quinn, Cecily
    Nodin, Bjorn
    Jirstrom, Karin
    Razmara, Fatemeh
    O'Grady, Anthony
    Baird, Anne-Marie
    Gray, Steven G.
    Freixo, Ana
    Moelans, Cathy B.
    van Diest, Paul J.
    Duffy, Michael J.
    O'Leary, Desmond
    Crown, John
    Bracken, Adrian P.
    Gallagher, William M.
    CLINICAL CHEMISTRY, 2022, 68 (06) : 837 - 847
  • [43] Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study
    LeVasseur, Nathalie
    Sun, Julia
    Fenton, David
    Baxter, Simon
    Chan, Angela
    Roberts, Sarah
    Feng, Xiaolan
    Lohrisch, Caroline
    Gelmon, Karen
    Shenkier, Tamara
    Chia, Stephen K.
    CLINICAL BREAST CANCER, 2022, 22 (01) : E74 - E79
  • [44] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Jessica F. Partin
    Eleftherios P. Mamounas
    Annals of Surgical Oncology, 2011, 18 : 3399 - 3406
  • [45] Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
    Hiroji Iwata
    Norikazu Masuda
    Yutaka Yamamoto
    Tomomi Fujisawa
    Tatsuya Toyama
    Masahiro Kashiwaba
    Shoichiro Ohtani
    Naruto Taira
    Takehiko Sakai
    Yoshie Hasegawa
    Rikiya Nakamura
    Hiromitsu Akabane
    Yukiko Shibahara
    Hironobu Sasano
    Takuhiro Yamaguchi
    Kentaro Sakamaki
    Helen Bailey
    Diana B. Cherbavaz
    Debbie M. Jakubowski
    Naoko Sugiyama
    Calvin Chao
    Yasuo Ohashi
    Breast Cancer Research and Treatment, 2019, 173 : 123 - 133
  • [46] Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
    Iwata, Hiroji
    Masuda, Norikazu
    Yamamoto, Yutaka
    Fujisawa, Tomomi
    Toyama, Tatsuya
    Kashiwaba, Masahiro
    Ohtani, Shoichiro
    Taira, Naruto
    Sakai, Takehiko
    Hasegawa, Yoshie
    Nakamura, Rikiya
    Akabane, Hiromitsu
    Shibahara, Yukiko
    Sasano, Hironobu
    Yamaguchi, Takuhiro
    Sakamaki, Kentaro
    Bailey, Helen
    Cherbavaz, Diana B.
    Jakubowski, Debbie M.
    Sugiyama, Naoko
    Chao, Calvin
    Ohashi, Yasuo
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (01) : 123 - 133
  • [47] Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
    Su Hyun Lee
    Seunggyun Ha
    Hyun Joon An
    Jae Sung Lee
    Wonshik Han
    Seock-Ah Im
    Han Suk Ryu
    Won Hwa Kim
    Jung Min Chang
    Nariya Cho
    Woo Kyung Moon
    Gi Jeong Cheon
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1574 - 1584
  • [48] Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
    Lee, Su Hyun
    Ha, Seunggyun
    An, Hyun Joon
    Lee, Jae Sung
    Han, Wonshik
    Im, Seock-Ah
    Ryu, Han Suk
    Kim, Won Hwa
    Chang, Jung Min
    Cho, Nariya
    Moon, Woo Kyung
    Cheon, Gi Jeong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1574 - 1584
  • [49] Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER plus ) node-negative breast cancer
    Albanell, J.
    Gonzalez, A.
    Ruiz-Borrego, M.
    Alba, E.
    Garcia-Saenz, J. A.
    Corominas, J. M.
    Burgues, O.
    Furio, V.
    Rojo, A.
    Palacios, J.
    Bermejo, B.
    Martinez-Garcia, M.
    Limon, M. L.
    Munoz, A. S.
    Martin, M.
    Tusquets, I.
    Rojo, F.
    Colomer, R.
    Faull, I.
    Lluch, A.
    ANNALS OF ONCOLOGY, 2012, 23 (03) : 625 - 631
  • [50] Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30
    Seho Park
    Yunan Han
    Ying Liu
    Adetunji T. Toriola
    Lindsay L. Peterson
    Graham A. Colditz
    Seung Il Kim
    Young Up Cho
    Byeong-Woo Park
    Yikyung Park
    Breast Cancer Research, 21
12345